PLACENTA ENCAPSULATION BUSINESS PLAN

I. Executive Summary

Company Description

Hearth Postpartum (name chosen to reflect care and biological warmth) is a U.S.-based provider of professional placenta encapsulation services launching in 2026. We operate an FDA-compliant laboratory and offer placental preparation, encapsulation, and temperature-controlled nationwide shipping for new mothers. Core activities include clinical-grade processing in our lab, validated cold-chain packaging and courier logistics, HIPAA-aligned intake and consent workflows, and licensed practitioner consultations to support safe postpartum use. One line: we turn a traditional wellness practice into a regulated, reliable nationwide service.

The business targets postpartum mothers and their care teams who seek safe, premium postpartum recovery options and value medical-grade protocols. We differentiate with rigorous safety standards, validated shipping technology, and centralized lab efficiency that enable consistent quality and broader access than local doulas or ad hoc providers. Short-term goals are to certify the lab, complete pilot shipments, and onboard referral clinical partners in 2026. Long-term goals are to standardize best practices across the industry, expand capacity to serve mothers nationwide, and develop allied postpartum products and clinical partnerships. One line: we professionalize postpartum placental services with safety, scale, and clinical credibility.

Problem

Many new mothers in the U.S. face sharp hormonal shifts and extreme fatigue during the fourth trimester, which slows physical recovery and worsens mood regulation. Standard postpartum care prioritizes medical checks and infant health but often overlooks natural, biological support options, leaving delays in maternal recovery, unmanaged emotional swings, limited access to trained providers, fragmented care, and unmet demand for reliable, evidence-informed postpartum options.

There is a clear gap: accessible, professional, holistic postpartum interventions that address hormones and energy are frequently unavailable or not integrated into standard care. One line: Mothers need accessible, professional postpartum support that addresses hormones and energy during the fourth trimester.

The company launches in 2026 as a U.S.-based provider offering placenta encapsulation through an FDA-compliant laboratory and temperature-controlled nationwide shipping, positioned to professionalize and reliably fill this unmet service gap.

Solution

New mothers face a rough fourth trimester: hormonal imbalance, exhaustion, and limited natural-care options. Many can’t find safe, professional, accessible encapsulation services, creating demand for a trustworthy, nationwide solution.

We offer a professional placenta encapsulation service that converts placental tissue into easy-to-consume capsules to support postpartum recovery. Key features: two preparation paths (Traditional Chinese Medicine and raw), lab-based processing for hygiene and consistency, end-to-end collection-to-delivery service, and clear dosing and storage guidance. The service targets hormone balance, energy restoration, and overall postpartum well-being.

One-liner: Dual-method, lab-standard encapsulation delivered end-to-end to meet the growing demand for safe, natural postpartum care.

Mission Statement

We empower new mothers through safe, professional placenta encapsulation that respects the transition to motherhood. Committed to clinical excellence, holistic wellness, and nationwide accessibility, we innovate logistics and uphold rigorous safety to set the gold standard for postpartum biological care.

Key Success Factors

These factors drive trust, scale, referrals, financial health, and customer value.

• Ensure safety and food-temperature compliance
• Deploy proprietary temperature-controlled shipping nationwide
• Leverage doula and midwife referral network
• Maintain 6-month breakeven and 13-month payback
• Offer tinctures, salves, and capsule product range

Financial Summary

Brief financial snapshot: the business achieves breakeven in June 2026 and scales to strong profitability and capital returns.

Financial requirements: minimum cash reserve of $865,000 (needed Feb-2026); marketing scales from $15,000 to $40,000 (2026–2028) while CAC falls from $150 to $140; payback occurs in 13 months and breakeven in Jun-2026.

Overall outlook: profitable from year one with rapid payback and strong EBITDA growth to $1,411,000 by 2030.

Funding Requirements

We require initial capitalization to cover capex, first‑year operating costs, 2026 marketing, founder salary, and a minimum cash reserve so the business reaches breakeven in Jun‑2026 and pays back investors in 13 months.